Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Charles River Laboratories Intl (($CRL)) has held its Q3 earnings call. Read on for the main highlights of the call. The ...

Poster presentations will preview new data from breakthrough bloodstream infection detection and oncology tests running on first-of-its-kind  Lilia-SEQ™ ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

Developing high-yielding, nutritious and climate-resilient crops is vital to safeguard the future of global food production.

The next-generation sequencing-based test is designed to capture all clinically relevant cystic fibrosis mutations in a single assay.

Whole-genome sequencing (WGS) of tumor and germline can generate actionable molecular insights that can guide precision medicine efforts in salivary gland cancer (SGC), according to a new study in JCO ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...

MiDOG Expands Scientific Advisory Board with the Appointment of Dr. Curtis Huttenhower, Dr. Micah Kohles, and Dr. Krista A. Keller Leaders in microbiome science, clinical practice, and exotic animal ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...